08:44 AM EDT, 05/08/2025 (MT Newswires) -- Haemonetics ( HAE ) reported fiscal Q4 adjusted earnings Thursday of $1.24 per diluted share, up from $0.90 a year earlier.

Analysts polled by FactSet expected $1.22.

Revenue for the quarter ended March 29 was $330.6 million compared with $343.3 million a year earlier.

Analysts surveyed by FactSet expected $329.4 million.

The company said it expects fiscal 2026 adjusted earnings of $4.70 to $5 per diluted share on report revenue growth of 3% to 6%. Analysts surveyed by FactSet expect adjusted earnings of $4.92 per share on revenue of $1.33 billion.

Shares of the company down nearly 2% in recent premarket activity.